Aditxt, Inc. Share-based Payment Arrangement, Expense, after Tax
Aditxt, Inc. (ADTX) reported Share-based Payment Arrangement, Expense, after Tax of $10.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-05-20
- Aditxt, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-12-31 was $0.00.
- Aditxt, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-09-30 was $0.00.
- Aditxt, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-06-30 was $0.00.
- Aditxt, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-03-31 was $10.00K, a 99.85% decline year-over-year.
- Aditxt, Inc. share-based payment arrangement, expense, after tax for fiscal 2025 was $10.00K, a 99.85% decline from fiscal 2024.
- Aditxt, Inc. share-based payment arrangement, expense, after tax for fiscal 2024 was $6.71M.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $10.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-11-18 | $10.00K 10-Q · filed 2025-11-18 | $10.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $10.00K 10-Q · filed 2025-08-14 | $10.00K derived: sum of 3 quarters · filed 2026-05-20 | $10.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-20 | $10.00K derived: sum of 2 quarters · filed 2026-05-20 | $10.00K derived: sum of 3 quarters · filed 2026-05-20 | $10.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $6.71M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-11-18 | $6.71M 10-Q · filed 2025-11-18 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $6.71M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $6.71M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |